# Pharmaceutical Aid Materials > Pharmaceutical aids notes for Pharmacy: diluents, binders, disintegrants, colours, sweeteners and preservatives with lactose, aspartame and Maillard interaction examples. - Canonical URL: https://prepelephant.com/topics/allied/pharmacy/pharmaceutical-aid-materials - Exam / course: Allied Health · Subject: Pharmacy - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Pharmaceutical Aid Materials", PrepElephant, https://prepelephant.com/topics/allied/pharmacy/pharmaceutical-aid-materials ## Direct answer Lactose does nothing pharmacologically — and that is exactly its job. Pharmaceutical aids (excipients) are the non-active substances that make a formulation manufacturable, stable, presentable and acceptable: diluents give bulk, binders hold granules together, disintegrants break tablets apart, lubricants and glidants run the press, colours and flavours make the dose tolerable, preservatives and antioxidants defend the molecule. The ideal excipient is inert, non-toxic, cheap, stable and compatible — but "inert" is always relative, and the syllabus's cautionary tales (lactose in galactosaemia, aspartame in phenylketonuria, the Maillard reaction with amine drugs) are precisely the cases examiners pick. ## What you must remember - Diluents: lactose (the most used), starch, microcrystalline cellulose, dibasic calcium phosphate, mannitol and sorbitol for chewable forms — mannitol dissolves endothermically, hence its cool mouthfeel. - Binders: starch paste, gelatin solution, polyvinylpyrrolidone, acacia, tragacanth, methylcellulose and HPMC. - Disintegrants: starch 5-10 per cent; superdisintegrants — croscarmellose sodium, sodium starch glycolate, crospovidone — at 2-5 per cent. - Glidants and lubricants: colloidal silicon dioxide (glidant), magnesium stearate and stearic acid (lubricants), talc for both. - Sweeteners: sucrose, sorbitol (non-cariogenic), mannitol, saccharin (hundreds of times sweeter than sucrose), aspartame (about 180-200 times), sucralose (about 600 times) — aspartame carries a phenylalanine warning for phenylketonurics. - Colours: natural (caramel, annatto, beta-carotene, turmeric) and synthetic permitted colours such as tartrazine and sunset yellow, used within limits fixed under the Drugs Rules; lakes for dry forms. - Preservatives: benzoic acid (effective below pH 5), parabens (methyl and propyl, often combined for spectrum), benzalkonium chloride for ophthalmics, chlorbutol, phenol and benzyl alcohol for injectables. - Antioxidants: ascorbic acid, sodium metabisulphite, BHA and BHT for oily phases, alpha-tocopherol; chelators such as EDTA sequester catalytic metal ions. - Suspending and emulsifying aids: tragacanth, xanthan, bentonite, methylcellulose; tweens (higher HLB) and spans (lower HLB) for emulsions. - The classic incompatibility: lactose with primary-amine drugs undergoes the Maillard (browning) reaction — the isoniazid-lactose pair is the standard example. ## Specifying excipients for one tablet, reasoned Formulate a chewable antacid tablet and each excipient becomes a decision with a reason. The diluent must taste pleasant and survive chewing: mannitol for its cooling sweetness, or sorbitol, compressible directly. Sucrose would work but adds cariogenic load for a product dosed repeatedly. The binder, if granulation is needed at all, is a mild PVP solution — strong binding is wrong here because the tablet must crumble pleasurably in the mouth, not fight the teeth. Flavour and colour follow paediatric appeal — a vanilla or orange flavour and a permitted lake stable to light. Magnesium stearate, minimal quantity, brief blend, lubricates ejection without waterproofing the antacid's fast reaction with gastric acid. Now invert the exercise into the viva's favourite format — "why not": why not lactose in this product (lactose intolerance and galactosaemia patients exist; also no functional benefit over mannitol here); why not aspartame in a paediatric product without a phenylalanine declaration; why not saccharin alone (bitter aftertaste at higher concentration, hence blending sweeteners). The examiner is listening for excipient choice as risk management, not as a memorised list. ## The "inert is relative" lesson Three documented interactions carry most of the marks. First, the Maillard reaction: reducing sugars like lactose react with drugs bearing primary amines — isoniazid, fluoxetine-type salts — browning and losing potency on storage; substitute dibasic calcium phosphate or microcrystalline cellulose and the problem disappears. Second, magnesium stearate's hydrophobicity: over-blended, it slows disintegration and dissolution, converting a compliant batch into a bioavailability failure — the phenytoin story from dosage-form history is the same lesson writ large. Third, preservative inactivation: benzalkonium chloride adsorbs onto suspending clays and some filters, and parabens partition into emulsion oil phases, so the measured preservative in the water phase falls below the effective level. Add the patient-safety layer that distinguishes a pharmacist from a formulator: excipients are medicines' hidden allergens and metabolic loads — lactose in galactosaemia, aspartame's phenylalanine in PKU, tartrazine sensitivity reactions, and the historical use of peanut oil in some formulations. Reading the excipient list is part of dispensing counselling, and Indian labels increasingly declare these warnings. ## Frequently asked questions ### Define pharmaceutical aids with three examples and their functions. Substances other than the active drug included to make the formulation manufacturable, stable or acceptable — lactose as diluent, croscarmellose sodium as disintegrant, magnesium stearate as lubricant. ### Why is mannitol preferred in chewable tablets? Its negative heat of solution produces a cool mouthfeel and it imparts sweetness with low cariogenicity, both desirable in a chewed dosage form. ### What is the Maillard reaction in formulation context? A browning reaction between reducing sugars (lactose) and drugs with primary amine groups, such as isoniazid, causing potency loss on storage; avoided by non-reducing diluents. ### Give two examples of excipient-patient interactions requiring label caution. Lactose in patients with galactosaemia or severe lactose intolerance, and aspartame as a phenylalanine source in phenylketonuria — both warrant excipient awareness at dispensing. ### Why are parabens often used in combination? Methylparaben and propylparaben together cover a broader microbial spectrum at lower total concentration than either alone, improving preservative efficacy at compatible solubility.